A study published in Nature Microbiology now shows for the first time that Candida auris uses a CO₂-based metabolic strategy to survive in the nutrient-poor conditions of the skin and to better tolerate antifungal therapies – especially amphotericin B (AMB).24. Dezember 2025
Health GLP-1s Help Lower Risk in People With DiabetesHealthradar16. Oktober 2025 Share on PinterestA new study found that GLP1-RA medications may help lower the risk of a cardiovascular event in people…
